Showing results (1-10 of 58) with videos related to
Sort By:
Pageof 6
Annual Review of Medicine|September 24, 2025
Optimizing KRAS Therapeutics for Non-Small Cell Lung CancerJeong Uk Lim, Marcelo V Negrao, David S HongNPJ Precision Oncology|April 16, 2024
BRAFV600E-mutant metastatic NSCLC: disease overview and treatment landscapeDavid Planchard, Rachel E Sanborn, Marcelo V Negrao, et al.Future Oncology (London, England)|December 13, 2025
Frontline sigvotatug vedotin plus pembrolizumab vs pembrolizumab for non-small cell lung cancer with PD-L1 tumor proportion score ≥50%: phase III study designMartin Reck, Shun Lu, Kenneth J O'Byrne, et al.Oral Oncology|April 2, 2023
Noninvasive genomic profiling of somatic mutations in oral cavity cancersYuanxin Xi, Marcelo V Negrao, Keiko Akagi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2023
Intracranial Efficacy of Adagrasib in Patients From the KRYSTAL-1 Trial With KRAS-Mutated Non-Small-Cell Lung Cancer Who Have Untreated CNS MetastasesMarcelo V Negrao, Alexander I Spira, Rebecca S Heist, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2026
Adaptive feedback signaling via the FAK/SRC pathway promotes KRAS G12C inhibitor resistanceHibiki Udagawa, Yuji Shibata, Monique B Nilsson, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 14, 2023
Neoadjuvant Targeted Therapy in Resectable NSCLC: Current and Future PerspectivesJay M Lee, Ciaran J McNamee, Eric Toloza, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 12, 2024
Mutational Characteristics and Clinical Outcomes for Lung Adenocarcinoma With EGFR Germline MutationsKelsey Pan, Jennifer Owens, Yasir Elamin, et al.Physiological Genomics|July 8, 2010
Exercise training improves muscle vasodilatation in individuals with T786C polymorphism of endothelial nitric oxide synthase geneMarcelo V Negrao, Cleber R Alves, Guilherme B Alves, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2021
Poziotinib for Patients With HER2 Exon 20 Mutant Non-Small-Cell Lung Cancer: Results From a Phase II TrialYasir Y Elamin, Jacqulyne P Robichaux, Brett W Carter, et al.Pageof 6